ATE463253T1 - In ovo schutz gegen infektiöse bronchitis - Google Patents

In ovo schutz gegen infektiöse bronchitis

Info

Publication number
ATE463253T1
ATE463253T1 AT01909239T AT01909239T ATE463253T1 AT E463253 T1 ATE463253 T1 AT E463253T1 AT 01909239 T AT01909239 T AT 01909239T AT 01909239 T AT01909239 T AT 01909239T AT E463253 T1 ATE463253 T1 AT E463253T1
Authority
AT
Austria
Prior art keywords
protection against
infectious bronchitis
against infectious
ovo
ovo protection
Prior art date
Application number
AT01909239T
Other languages
English (en)
Inventor
Berend Jongsma
Frans Davelaar
Marinus Weststrate
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/775,750 external-priority patent/US20010046500A1/en
Application filed by Wyeth Llc filed Critical Wyeth Llc
Application granted granted Critical
Publication of ATE463253T1 publication Critical patent/ATE463253T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Feed For Specific Animals (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT01909239T 2000-02-29 2001-02-15 In ovo schutz gegen infektiöse bronchitis ATE463253T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US51573200A 2000-02-29 2000-02-29
US09/775,750 US20010046500A1 (en) 2000-02-29 2001-02-02 In ovo protection against infectious bronchitis
PCT/US2001/004792 WO2001064244A2 (en) 2000-02-29 2001-02-15 In ovo protection against infectious bronchitis

Publications (1)

Publication Number Publication Date
ATE463253T1 true ATE463253T1 (de) 2010-04-15

Family

ID=27058588

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01909239T ATE463253T1 (de) 2000-02-29 2001-02-15 In ovo schutz gegen infektiöse bronchitis

Country Status (20)

Country Link
EP (2) EP1259257B1 (de)
JP (1) JP2003529565A (de)
CN (1) CN1406135A (de)
AR (1) AR027558A1 (de)
AT (1) ATE463253T1 (de)
AU (1) AU2001237016A1 (de)
BR (1) BR0108735A (de)
CA (1) CA2401145A1 (de)
CY (1) CY1110544T1 (de)
DE (1) DE60141743D1 (de)
DK (1) DK1259257T3 (de)
ES (1) ES2341841T3 (de)
IL (1) IL151039A0 (de)
MX (1) MXPA02008254A (de)
NO (1) NO20024100L (de)
NZ (1) NZ520761A (de)
PL (1) PL365447A1 (de)
PT (1) PT1259257E (de)
WO (1) WO2001064244A2 (de)
YU (1) YU65102A (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR031405A1 (es) 2000-11-21 2003-09-24 Wyeth Corp Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
WO2004078203A2 (en) * 2003-03-03 2004-09-16 Akzo Nobel N.V. Infectious bronchitis virus with an altered spike gene
WO2007072916A1 (ja) * 2005-12-22 2007-06-28 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 卵内接種用ワクチン
CN109641043A (zh) 2016-06-16 2019-04-16 勃林格殷格翰动物保健有限公司 针对感染性支气管炎病毒的疫苗
CN112996537A (zh) 2018-10-31 2021-06-18 勃林格殷格翰动物保健有限公司 具有异源刺突蛋白的4/91 ibv疫苗
CN112996536A (zh) 2018-10-31 2021-06-18 勃林格殷格翰动物保健有限公司 具有异源刺突蛋白的h52 ibv疫苗
CN114126645A (zh) 2019-05-10 2022-03-01 勃林格殷格翰动物保健有限公司 冠状病毒刺突蛋白的修饰的s1亚基
US20220213148A1 (en) 2019-05-10 2022-07-07 Boehringer Ingelheim Vetmedica Gmbh Modified s2 subunit of the coronavirus spike protein
MX2021013728A (es) 2019-05-10 2021-12-10 Boehringer Ingelheim Vetmedica Gmbh Ibv atenuado con tropismo de cultivo celular y tisular extendido.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE196773T1 (de) * 1993-07-30 2000-10-15 Akzo Nobel Nv Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff
US6506385B1 (en) * 1998-04-17 2003-01-14 Embrex, Inc. Live vaccines and methods of treatment therewith

Also Published As

Publication number Publication date
EP2198883A1 (de) 2010-06-23
AR027558A1 (es) 2003-04-02
PT1259257E (pt) 2010-06-01
WO2001064244A2 (en) 2001-09-07
JP2003529565A (ja) 2003-10-07
CA2401145A1 (en) 2001-09-07
NO20024100D0 (no) 2002-08-28
IL151039A0 (en) 2003-04-10
MXPA02008254A (es) 2003-02-06
CY1110544T1 (el) 2015-04-29
EP1259257A2 (de) 2002-11-27
EP1259257B1 (de) 2010-04-07
WO2001064244A3 (en) 2002-01-31
AU2001237016A1 (en) 2001-09-12
PL365447A1 (en) 2005-01-10
DE60141743D1 (de) 2010-05-20
BR0108735A (pt) 2002-12-17
YU65102A (sh) 2005-09-19
DK1259257T3 (da) 2010-06-14
NO20024100L (no) 2002-10-09
CN1406135A (zh) 2003-03-26
NZ520761A (en) 2004-10-29
ES2341841T3 (es) 2010-06-29

Similar Documents

Publication Publication Date Title
NO20026175L (no) Vaksinesammensetning
GB2366693B (en) Software virus protection
GB2366692B (en) Virus protection in an internet environment
NO20024172D0 (no) Vaksine
NO20030823L (no) Vaksiner
NO20031705D0 (no) Vaksiner
DE10153005B4 (de) Hartmetall-Schaftfräser
NO20030239D0 (no) Modifisert virus
DE60133154D1 (de) Antistatische Zusammensetzung
ITMI20000901A0 (it) Fluoroelastomeri
DK1132666T3 (da) Stövbeskyttelse
DE60141743D1 (de) In ovo schutz gegen infektiöse bronchitis
DE60012415D1 (de) Virtuelles Postschliessfach
DE60104315D1 (de) Fingerschutzanordnung
ATE264615T1 (de) Hufschutz
ATA372000A (de) Texturierdüse
DE60125927D1 (de) Impfstoffe gegen hiv
NO20024360D0 (no) Sikkerhetsstang-overföringsmekanismesammenstilling
SE0002005A0 (sv) Ballistiskt skydd
ID29716A (id) Peranti pelindung
DE50114582D1 (de) Texturierdüse
IS6184A (is) Bóluefni gegn ISA veiru
DE60034503D1 (de) Schlossschutz
FI20001377A0 (fi) Murtosuojapostilaatikko
DE60200894D1 (de) Schutzstruktur gegen Störungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1259257

Country of ref document: EP